跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CON-Z-LIN TABLET - HSA Drug Approval Details
Approvals
/
HSA
/
CON-Z-LIN TABLET
Approved
THERAPEUTIC
CON-Z-LIN TABLET
SUNWARD PHARMACEUTICAL PRIVATE LIMITED (SINGAPORE)
🇸🇬 Health Sciences Authority
Approval Date
Apr 22, 1991
Approval ID
eb68259ade74e9cb
Company
SUNWARD PHARMACEUTICAL PRIVATE LIMITED (SINGAPORE)
Type
Therapeutic
Approval Details
Approval Id
eb68259ade74e9cb
Drug Name
CON-Z-LIN TABLET
Product Name
CON-Z-LIN TABLET
Approval Number
SIN05768P
Approval Date
1991-04-22
Registrant
CENTRAL CHEMICAL & ENTERPRISES PTE. LTD.
Licence Holder
CENTRAL CHEMICAL & ENTERPRISES PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
General Sale List
Dosage Form
TABLET, SUGAR COATED
Route Of Administration
ORAL
Atc Code
N02BA55
Atc Item Name
salicylamide, combinations excl. psycholeptics
Pharma Manufacturer Name
CENTRAL CHEMICAL & ENTERPRISES PTE. LTD.
Active Ingredients
SALICYLAMIDE
250 mg
CAFFEINE (ANHYDROUS)
15 mg
CAFFEINE (ANHYDROUS)
15 MG
SALICYLAMIDE
250 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Apr 22, 1991
Approval ID
eb68259ade74e9cb
Type
Therapeutic
Back to HSA Approvals